Last updated on June 2017

Safety and Efficacy of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension


Brief description of study

This study will evaluate the efficacy and safety of bimatoprost sustained-release (SR) in patients with open-angle glaucoma or ocular hypertension. The study includes a 12-month treatment period with an 8-month extended follow-up.

Clinical Study Identifier: NCT02250651

Contact Investigators or Research Sites near you

Start Over

Clinical Trial Registry Team

4135 Rue de Rouen
Montreal, QC Canada
1.87miles
  Connect »